More

    Junshi Biosciences Announces Approval of sNDA for Toripalimab in Combination with Bevacizumab for 1st-line Treatment of Advanced Hepatocellular Carcinoma



    [
    Junshi Biosciences Announces Approval of sNDA for Toripalimab in Combination with Bevacizumab for 1st-line Treatment of Advanced Hepatocellular Carcinoma
    [og_img]
    https://www.investing.com/news/press-releases/junshi-biosciences-announces-approval-of-snda-for-toripalimab-in-combination-with-bevacizumab-for-1stline-treatment-of-advanced-hepatocellular-carcinoma-93CH-3943493


    Investing.com

    Latest articles

    spot_imgspot_img

    Related articles

    Leave a reply

    Please enter your comment!
    Please enter your name here

    spot_imgspot_img